Adequan I.m. 100 mg (Glycosaminoglycan Polysulfate SOLUTION) 100 MG

Adequan I.M. 100 MG is a glycosaminoglycan polysulfate solution for intramuscular use. It supports joint health and mobility, often used for conditions like osteoarthritis. Learn more about its benefits and uses.

Strength

100 MG

Manufacturer / TM Owner

AMERICAN REGENT, INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Adequan I.M. 100 MG is primarily used to support joint health and mobility. It is often administered for conditions that affect joint function, such as osteoarthritis. This solution is designed to help maintain the integrity of cartilage and promote joint lubrication. Many users seek Adequan I.M. for its potential to alleviate joint discomfort and improve mobility.

Side Effects

Common effects of Adequan I.M. 100 MG may include temporary discomfort at the injection site. Some users report improved joint function and reduced stiffness over time. Individual responses can vary, and it is important to monitor for any adverse reactions.

Precautions & Warnings

Adequan I.M. 100 MG should be handled with care, ensuring proper sterile techniques during administration. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Always store the solution as directed to maintain its efficacy.

Avoid Interactions

Adequan I.M. 100 MG may interact with other medications, particularly those that affect blood clotting or immune response. It is advisable to consult a healthcare professional before combining it with other treatments. Alcohol and certain supplements may also influence its effects.

Frequently Asked Questions

Adequan I.M. 100 MG is used to support joint health and mobility, often for conditions like osteoarthritis.

Adequan I.M. 100 MG is administered via intramuscular injection, typically by a healthcare professional.

Common effects may include temporary discomfort at the injection site and improved joint function over time.

It is important to consult a healthcare professional before combining Adequan I.M. 100 MG with other medications.

Adequan I.M. 100 MG should be stored as directed, typically in a cool, dry place away from direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.